| Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial M Backonja, A Beydoun, KR Edwards, SL Schwartz, V Fonseca, M Hes, ... Jama 280 (21), 1831-1836, 1998 | 2164 | 1998 |
| Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy [RETIRED] Report of the Therapeutics and Technology Assessment Subcommittee and … JA French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ... Neurology 62 (8), 1261-1273, 2004 | 928* | 2004 |
| Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy [RETIRED] Report of the Therapeutics and Technology Assessment Subcommittee and … JA French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ... Neurology 62 (8), 1252-1260, 2004 | 645 | 2004 |
| Cerebral processing of acute skin and muscle pain in humans P Svensson, S Minoshima, A Beydoun, TJ Morrow, KL Casey Journal of neurophysiology 78 (1), 450-460, 1997 | 353 | 1997 |
| Variability of laser-evoked potentials: attention, arousal and lateralized differences A Beydoun, TJ Morrow, JF Shen, KL Casey Electroencephalography and Clinical Neurophysiology/Evoked Potentials …, 1993 | 294 | 1993 |
| Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy A Beydoun, BM Uthman, AR Kugler, MJ Greiner, LE Knapp, EA Garofalo, ... Neurology 64 (3), 475-480, 2005 | 252 | 2005 |
| Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial A Beydoun, RC Sachdeo, WE Rosenfeld, GL Krauss, N Sessler, ... Neurology 54 (12), 2245-2251, 2000 | 190 | 2000 |
| Valproate‐induced thrombocytopenia: a prospective monotherapy study W Nasreddine, A Beydoun Epilepsia 49 (3), 438-445, 2008 | 174 | 2008 |
| Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures A Beydoun, J D’Souza, D Hebert, P Doty Expert review of neurotherapeutics 9 (1), 33-42, 2009 | 171 | 2009 |
| Safety and tolerability of oxcarbazepine in elderly patients with epilepsy E Kutluay, K McCague, J D’Souza, A Beydoun Epilepsy & Behavior 4 (2), 175-180, 2003 | 164 | 2003 |
| Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial A Beydoun, JC Sackellares, V Shu Neurology 48 (1), 182-188, 1997 | 157 | 1997 |
| Safety and efficacy of oxcarbazepine: results of randomized, double‐blind trials A Beydoun Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (8P2 …, 2000 | 154 | 2000 |
| Gabapentin: pharmacokinetics, efficacy, and safety A Beydoun, BM Uthman, JC Sackellares Clinical neuropharmacology 18 (6), 469-481, 1995 | 154 | 1995 |
| Focal cerebral magnetic resonance changes associated with partial status epilepticus TR Henry, I Drury, JA Brunberg, PB Pennell, PE McKeever, A Beydoun Epilepsia 35 (1), 35-41, 1994 | 125 | 1994 |
| Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures R Sachdeo, A Beydoun, S Schachter, B Vazquez, N Schaul, ... Neurology 57 (5), 864-871, 2001 | 124 | 2001 |
| Interictal epileptiform activity in elderly patients with epilepsy I Drury, A Beydoun Electroencephalography and clinical neurophysiology 106 (4), 369-373, 1998 | 124 | 1998 |
| Oxcarbazepine A Beydoun, E Kutluay Expert Opinion on Pharmacotherapy 3 (1), 59-71, 2002 | 120 | 2002 |
| Oxcarbazepine in painful diabetic neuropathy: results of a dose‐ranging study A Beydoun, A Shaibani, M Hopwood, Y Wan Acta Neurologica Scandinavica 113 (6), 395-404, 2006 | 118 | 2006 |
| Mechanistic stratification of antineuralgic agents A Beydoun, MM Backonja Journal of pain and symptom management 25 (5), S18-S30, 2003 | 117 | 2003 |
| Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia AT Taher, KM Musallam, W Nasreddine, R Hourani, A Inati, A Beydoun Journal of Thrombosis and Haemostasis 8 (1), 54-59, 2010 | 111 | 2010 |
